# name
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

# metadata.dc.description.abstract[].value
The objective of this study was to estimate the cost-effectiveness of denosumab for fracture prevention compared with no treatment, generic bisphosphonates, and strontium ranelate in a cohort of osteoporotic postmenopausal women in Spain.

# metadata.dc.relation.ispartof[].value
Clinicoeconomics and Outcomes Research, 2015, vol. 2015, num. 7, p. 105-117

# metadata.dc.source[].value
Articles publicats en revistes (Economia)

# metadata.dc.title[].value
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain